CV Sciences (CVSI) Receivables - Other (2013 - 2023)
CV Sciences (CVSI) posted Receivables - Other of $6.4 million for Q1 2023, little changed sequentially from $6.4 million in Q4 2022, and little changed YoY from $6.4 million in Q1 2022.
CV Sciences (CVSI) Receivables - Other (2013 - 2023) Analysis & Trends
CV Sciences has reported Receivables - Other for 9 years, with the latest figure at $6.4 million in Q1 2023.
- Quarterly Receivables - Other changed 0.0% year-over-year to $6.4 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $6.4 million (changed 0.0% YoY) and the FY2022 annual result came in at $6.4 million, up 2033.33% from the prior year.
- Receivables - Other was little changed at $6.4 million in Q1 2023 per CVSI's latest filing, from $6.4 million in the prior quarter.
- Over five years, Receivables - Other peaked at $6.4 million in Q3 2019 and troughed at $300000.0 in Q4 2021.
- A 5-year average of $5.9 million and a median of $6.4 million in 2019 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2021 and 2022: Receivables - Other tumbled 95.31% in 2021, then surged 2033.33% in 2022.
- Over 5 years, Receivables - Other stood at $6.4 million in 2019, then changed by 0.0% to $6.4 million in 2020, then sank by 95.31% to $300000.0 in 2021, then soared by 2033.33% to $6.4 million in 2022, then changed by 0.0% to $6.4 million in 2023.
- According to Business Quant data, Receivables - Other over the past three periods registered $6.4 million, $6.4 million, and $6.4 million for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 6.40 Mn |
| Mar 31, 2023 | 6.40 Mn |
| Dec 31, 2022 | 6.40 Mn |
| Dec 31, 2022 | 6.40 Mn |
| Sep 30, 2022 | 6.40 Mn |
| Sep 30, 2022 | 6.40 Mn |
| Jun 30, 2022 | 6.40 Mn |
| Jun 30, 2022 | 6.40 Mn |
| Mar 31, 2022 | 6.40 Mn |
| Mar 31, 2022 | 6.40 Mn |
| Dec 31, 2021 | 300,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 6.40 Mn |
| Sep 30, 2021 | 6.40 Mn |
| Jun 30, 2021 | 6.40 Mn |
| Jun 30, 2021 | 6.40 Mn |
| Mar 31, 2021 | 6.40 Mn |
| Mar 31, 2021 | 6.40 Mn |
| Dec 31, 2020 | 6.40 Mn |
| Dec 31, 2020 | 6.40 Mn |